Method for treating amyloid disease
First Claim
Patent Images
1. A polymerized form of an immunogenic modified Aβ
- peptide, which peptide contains Lysine substitutions in amino acid positions corresponding to amino acids 18 and 19 of Aβ
1-42, which polymerized form is covalently bonded to an adjuvant polypeptide when produced using controlled polymerization with glutaraldehyde, and is soluble and non-fibrillogenic.
1 Assignment
0 Petitions
Accused Products
Abstract
The invention relates to methods for treating human amyloid disease by administration of modified Aβ peptide immunogens.
43 Citations
16 Claims
-
1. A polymerized form of an immunogenic modified Aβ
- peptide, which peptide contains Lysine substitutions in amino acid positions corresponding to amino acids 18 and 19 of Aβ
1-42, which polymerized form is covalently bonded to an adjuvant polypeptide when produced using controlled polymerization with glutaraldehyde, and is soluble and non-fibrillogenic. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)
- peptide, which peptide contains Lysine substitutions in amino acid positions corresponding to amino acids 18 and 19 of Aβ
Specification